A
Abdominal obesity
Acanthosis nigricans
B
Bardet–Biedl syndrome
Blood sugar regulation
Burnt-out diabetes mellitus
C
Combined hyperlipidemia
D
Diabetes mellitus
Diabetes mellitus type 2
Diseases of affluence (coronary heart disease, cerebrovascular disease, peripheral vascular disease, certain forms of cancer, asthma, alcoholism, gout, allergies and depression,
E
Essential hypertension
F
Fatty liver
G
Gastroesophageal reflux disease
Genu valgum
Gynecomastia
H
Hemorrhoid
Hypercholesterolemia
Hypertension
Hypertriglyceridemia
I
Infertility in polycystic ovary syndrome
L
Laminopathy
M
Metabolic syndrome
Muscle atrophy
N
Non-ketonic hyperglycemic coma
O
Obesity hypoventilation syndrome
Obstructive sleep apnea
P
Pelvic lipomatosis
Polycystic ovary syndrome
Portal-visceral hypothesis
Prader–Willi syndrome
Prediabetes
R
S
Stretch marks
V
Varicose veins
08 May, 2011
FATTY LIVER
Fatty liver, also known as fatty liver disease (FLD), is a reversible condition where large vacuoles of triglyceride fat accumulate in liver cells via the process of steatosis (i.e. abnormal retention of lipids within a cell). Despite having multiple causes, fatty liver can be considered a single disease that occurs worldwide in those with excessive alcohol intake and those who are obese (with or without effects of insulin resistance). The condition is also associated with other diseases that influence fat metabolism. Morphologically it is difficult to distinguish alcoholic FLD from non alcoholic FLD and both show micro-vesicular and macrovesicular fatty changes at different stages.
Accumulation of fat may also be accompanied by a progressive inflammation of the liver (hepatitis), called steatohepatitis. By considering the contribution by alcohol, fatty liver may be termed alcoholic steatosis or non-alcoholic fatty liver disease (NAFLD), and the more severe forms as alcoholic steatohepatitis (part of alcoholic liver disease) and non-alcoholic steatohepatitis (NASH).
Fatty liver is commonly associated with alcohol or metabolic syndrome (diabetes, hypertension, obesity and dyslipidemia) but can also be due to any one of many causes
Metabolic causes
Abetalipoproteinemia, glycogen storage diseases, Weber-Christian disease, acute fatty liver of pregnancy, lipodystrophy
Nutritional causes
Malnutrition, total parenteral nutrition, severe weight loss, refeeding syndrome, jejuno-ileal bypass, gastric bypass, jejunal diverticulosis with bacterial overgrowth
Drugs and toxins
Amiodarone, methotrexate, diltiazem, highly active antiretroviral therapy, glucocorticoids, tamoxifen, environmental hepatotoxins (e.g., phosphorus, mushroom poisoning)
Others
Inflammatory bowel disease, HIV, Hepatitis C especially genotype 3, and Alpha 1-antitrypsin deficiency
Accumulation of fat may also be accompanied by a progressive inflammation of the liver (hepatitis), called steatohepatitis. By considering the contribution by alcohol, fatty liver may be termed alcoholic steatosis or non-alcoholic fatty liver disease (NAFLD), and the more severe forms as alcoholic steatohepatitis (part of alcoholic liver disease) and non-alcoholic steatohepatitis (NASH).
Fatty liver is commonly associated with alcohol or metabolic syndrome (diabetes, hypertension, obesity and dyslipidemia) but can also be due to any one of many causes
Metabolic causes
Abetalipoproteinemia, glycogen storage diseases, Weber-Christian disease, acute fatty liver of pregnancy, lipodystrophy
Nutritional causes
Malnutrition, total parenteral nutrition, severe weight loss, refeeding syndrome, jejuno-ileal bypass, gastric bypass, jejunal diverticulosis with bacterial overgrowth
Drugs and toxins
Amiodarone, methotrexate, diltiazem, highly active antiretroviral therapy, glucocorticoids, tamoxifen, environmental hepatotoxins (e.g., phosphorus, mushroom poisoning)
Others
Inflammatory bowel disease, HIV, Hepatitis C especially genotype 3, and Alpha 1-antitrypsin deficiency
know ur glucose level by looking into ur eyes!!
The body can be a confusing place, and when you’re ill sometimes you just wish you could see what the problem is. For diabetics, that wish may be coming true. Professor Jin Zhang at the University of Western Ontario has developed contact lenses that would change color as the user’s glucose levels varied. The new device is made by embedding nanoparticles into standard hydrogel. These particles react with glucose in the tears and change color. The colour change is slight, but it could alert diabetics to dangerous sugar levels without the need for regular blood tests. According to the University’s News site.
While it could be very useful for diaetes in theory, the nanoparticle embedding process is probably going to find better applications outside of medicine. Passive monitoring through a contact lens, while ingenious, doesn’t seem like the most economic approach. And we’ve already seen how stem cell treatments, or implants, are likely to help fight or even cure diabetes in the future.
While it could be very useful for diaetes in theory, the nanoparticle embedding process is probably going to find better applications outside of medicine. Passive monitoring through a contact lens, while ingenious, doesn’t seem like the most economic approach. And we’ve already seen how stem cell treatments, or implants, are likely to help fight or even cure diabetes in the future.
World diabetes day
World Diabetes Day is the primary global awareness campaign of the diabetes mellitus world and is held on November 14 of each year. It was introduced in 1991 by the International Diabetes Federation and the World Health Organization in response to the alarming rise of diabetes around the world. World Diabetes Day is a campaign that features a new theme chosen by the International Diabetes Federation each year to address issues facing the global diabetes community. While the campaigns last the whole year, the day itself marks the birthday of Frederick Banting who, along with Charles Best, first conceived the idea which led to the discovery of insulin in 1922.
Each year, World Diabetes Day is centred on a theme related to diabetes. Topics covered have included diabetes and human rights, diabetes and lifestyle, diabetes and obesity, diabetes in the disadvantaged and the vulnerable, and diabetes in children and adolescents.
For 2009–2013, the theme is Diabetes Education and Prevention.
Each year, World Diabetes Day is centred on a theme related to diabetes. Topics covered have included diabetes and human rights, diabetes and lifestyle, diabetes and obesity, diabetes in the disadvantaged and the vulnerable, and diabetes in children and adolescents.
For 2009–2013, the theme is Diabetes Education and Prevention.
GLYCATED HEMOGLOBIN ( HbA1c)
Glycated hemoglobin (glycosylated hemoglobin, hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also HbA1c) is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose. Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous months prior to the measurement.
In diabetes mellitus, higher amounts of glycated hemoglobin, indicating poorer control of blood glucose levels, have been associated with cardiovascular disease, nephropathy, and retinopathy.
In the normal 120-day lifespan of the red blood cell, glucose molecules react with hemoglobin, forming glycated hemoglobin. In individuals with poorly controlled diabetes, the quantities of these glycated hemoglobins are much higher than in healthy people.
Once a hemoglobin molecule is glycated, it remains that way. A buildup of glycated hemoglobin within the red cell, therefore, reflects the average level of glucose to which the cell has been exposed during its life-cycle. Measuring glycated hemoglobin assesses the effectiveness of therapy by monitoring long-term serum glucose regulation. The HbA1c level is proportional to average blood glucose concentration over the previous four weeks to three months. Some researchers state that the major proportion of its value is related to a rather shorter period of two to four weeks.
In diabetes mellitus, higher amounts of glycated hemoglobin, indicating poorer control of blood glucose levels, have been associated with cardiovascular disease, nephropathy, and retinopathy.
In the normal 120-day lifespan of the red blood cell, glucose molecules react with hemoglobin, forming glycated hemoglobin. In individuals with poorly controlled diabetes, the quantities of these glycated hemoglobins are much higher than in healthy people.
Once a hemoglobin molecule is glycated, it remains that way. A buildup of glycated hemoglobin within the red cell, therefore, reflects the average level of glucose to which the cell has been exposed during its life-cycle. Measuring glycated hemoglobin assesses the effectiveness of therapy by monitoring long-term serum glucose regulation. The HbA1c level is proportional to average blood glucose concentration over the previous four weeks to three months. Some researchers state that the major proportion of its value is related to a rather shorter period of two to four weeks.
Subscribe to:
Posts (Atom)
